Univariate analyses of the clinical factors that influenced EFS
| . | Mean ± SD . | Relative risk . | (95% CI) . | P . |
|---|---|---|---|---|
| Risk strata | 49/113 high risk | 3.6 | (2.2-5.9) | < .0001 |
| Patient age | 43 ± 11 | 1.00 | (0.98-1.03) | .74 |
| Donor age | 42 ± 11 | 1.00 | (0.98-1.02) | .83 |
| Male gender | 69/113 | 1.90 | (1.12-3.20) | .017 |
| TBI | 10/113 | 2.26 | (1.08-4.76) | .031 |
| G-CSF or GM-CSF after transplantation | 42/113 | 1.6 | (0.98-2.6) | .058 |
| . | Mean ± SD . | Relative risk . | (95% CI) . | P . |
|---|---|---|---|---|
| Risk strata | 49/113 high risk | 3.6 | (2.2-5.9) | < .0001 |
| Patient age | 43 ± 11 | 1.00 | (0.98-1.03) | .74 |
| Donor age | 42 ± 11 | 1.00 | (0.98-1.02) | .83 |
| Male gender | 69/113 | 1.90 | (1.12-3.20) | .017 |
| TBI | 10/113 | 2.26 | (1.08-4.76) | .031 |
| G-CSF or GM-CSF after transplantation | 42/113 | 1.6 | (0.98-2.6) | .058 |
Separate regression analyses were performed for the entire group of patients (n = 113) using each covariate listed. Significant (P < .05) associations of covariates with EFS are in bold.